Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Kymera Therapeutics (KYMR) and NovoCure (NVCR)

TipRanksNov 5 07:40 ET · Ratings

NovoCure's Strong Q3 and Leadership Changes in 2024

Yahoo FinanceOct 31 07:30 ET

NovoCure Analyst Ratings

BenzingaOct 31 05:33 ET · Ratings

NovoCure (NVCR) Q3 2024 Earnings Call Transcript

Yahoo FinanceOct 30 23:00 ET

NovoCure Limited (NVCR) Q3 2024 Earnings Conference Call Transcript Summary

moomoo AIOct 30 11:55 ET · Conference Call

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsOct 30 11:31 ET · Ratings